相关实验视频

Updated: Jul 2, 2025

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

在不同类型的瘤中,瘤衍生的萨科佩尼亚因素是不同的:全癌症分析

Xin Gan¹, Yunqian Zeng¹, Jiaquan Huang²

¹Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

|February 24, 2024

概括

与癌症相关的肌肉衰竭 (肉类衰竭) 与瘤分泌物有关. 研究人员在瘤中确定了与肌肉损失和患者存活相关的特定分泌基因,突出了癌症类型的多样化机制.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

与癌症相关的肌肉衰竭 (肉类衰竭) 显著增加了癌症患者的发病率和死亡率.
特定的瘤衍生因素驱动萨尔科佩尼亚及其机制在很大程度上是未知的.
了解这些因素对于制定有针对性的干预措施至关重要.

研究的目的:

为了确定瘤分子和分泌特征在癌症患者和没有sarcopenia之间的差异.
发现与肉症和患者预后相关的新型瘤分泌生物标志物.
探索各种瘤衍生因素的多样性,这些因素有助于不同类型癌症的肌肉消耗.

主要方法:

整合了癌症基因组图谱 (TCGA) 转录组数据与放射学数据,以计算骨肌面积 (SMA) 并识别肉症.
分析了10种瘤类型的高调分泌基因与使用TCGA和GTEx数据的正常组织相比.
与SMA相关的分泌基因表达,并验证了它们对患者生存的预测价值.

主要成果:

在研究队列中发现了显著的肉类的患病率 (24.28%).
在瘤中发现了与肌肉损耗相关的途径的丰富,这些瘤具有较高的肉类症率.
发现了与SMA相关的分泌基因,具有不同瘤类型的表达特征,预测患者的预后 (p ≤ 0.002).

结论:

瘤分泌体的特征与肉症密切相关,具有影响生存的特定介质.
瘤衍生的亲肉性因素在不同癌症类型和性别之间存在显著差异,表明复杂和多样化的机制.
这些发现表明,对于与癌症相关的肌肉衰竭,需要个性化治疗方法.

关键词:

在TCGA中,TCGA就是TCGA.癌症成像档案癌症成像档案与癌症相关的肌肉衰竭癌分析分析癌分析由瘤衍生的因素.瘤分泌的瘤分泌的

更多相关视频

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...